← Kering SA overview

Kering SA vs Hermes International SCA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Kering SA (KER.PA)

Q3 2026
▲3▼1

Kering's Gucci turnaround gains traction, but tariff probe and $400M exit cost linger

  • Gucci turnaround drives 15%+ share surge Kering shares jumped about 15-17% after Q2 results showed Gucci's sales fell only 2% organically, far less than feared, and leather goods returned to growth. Analysts upgraded the stock, with HSBC raising its target to €340. This is the main force pushing KER.PA up.

    This is the biggest new event of the period and directly explains the sharp share price move.

  • First-half return to growth and debt cut Kering reported H1 2026 revenue up 1% and Q2 up 2%, with operating margin improving to 12.8%. Net debt fell by €4.7 billion to €3.3 billion, helped by €2.6 billion free cash flow. This supports the recovery story and gives the company more financial room.

    These results underpin the positive share move and show the turnaround is more than just Gucci.

  • Jewelry becomes a growth engine Kering's jewelry sales rose 22% in Q1, the fastest among its businesses, as consumers shift toward jewelry amid high gold prices and fashion fatigue. This trend, seen across the luxury sector, gives Kering a valuable second growth driver beyond Gucci.

    It highlights a structural positive for Kering's revenue mix that investors are rewarding.

  • Tariff refund probe and $400M Gucci Beauty exit cost Kering faces a class-action investigation over whether it kept tariff-related price hikes after tariffs were struck down, a potential legal and reputational risk. It also paid $400 million to end the Gucci beauty license early, a cash cost that partly offsets the positive results.

    These are real counterweights that could weigh on the stock and are new this period.

July 2026
▲3▼1

Kering's Gucci turnaround gains traction, but tariff probe and $400M exit cost linger

  • Gucci turnaround drives 15%+ share surge Kering shares jumped about 15-17% after Q2 results showed Gucci's sales fell only 2% organically, far less than feared, and leather goods returned to growth. Analysts upgraded the stock, with HSBC raising its target to €340. This is the main force pushing KER.PA up.

    This is the biggest new event of the period and directly explains the sharp share price move.

  • First-half return to growth and debt cut Kering reported H1 2026 revenue up 1% and Q2 up 2%, with operating margin improving to 12.8%. Net debt fell by €4.7 billion to €3.3 billion, helped by €2.6 billion free cash flow. This supports the recovery story and gives the company more financial room.

    These results underpin the positive share move and show the turnaround is more than just Gucci.

  • Jewelry becomes a growth engine Kering's jewelry sales rose 22% in Q1, the fastest among its businesses, as consumers shift toward jewelry amid high gold prices and fashion fatigue. This trend, seen across the luxury sector, gives Kering a valuable second growth driver beyond Gucci.

    It highlights a structural positive for Kering's revenue mix that investors are rewarding.

  • Tariff refund probe and $400M Gucci Beauty exit cost Kering faces a class-action investigation over whether it kept tariff-related price hikes after tariffs were struck down, a potential legal and reputational risk. It also paid $400 million to end the Gucci beauty license early, a cash cost that partly offsets the positive results.

    These are real counterweights that could weigh on the stock and are new this period.

Latest
▲3▼1

Kering's Gucci turnaround gains traction, but tariff probe and $400M exit cost linger

  • Gucci turnaround drives 15%+ share surge Kering shares jumped about 15-17% after Q2 results showed Gucci's sales fell only 2% organically, far less than feared, and leather goods returned to growth. Analysts upgraded the stock, with HSBC raising its target to €340. This is the main force pushing KER.PA up.

    This is the biggest new event of the period and directly explains the sharp share price move.

  • First-half return to growth and debt cut Kering reported H1 2026 revenue up 1% and Q2 up 2%, with operating margin improving to 12.8%. Net debt fell by €4.7 billion to €3.3 billion, helped by €2.6 billion free cash flow. This supports the recovery story and gives the company more financial room.

    These results underpin the positive share move and show the turnaround is more than just Gucci.

  • Jewelry becomes a growth engine Kering's jewelry sales rose 22% in Q1, the fastest among its businesses, as consumers shift toward jewelry amid high gold prices and fashion fatigue. This trend, seen across the luxury sector, gives Kering a valuable second growth driver beyond Gucci.

    It highlights a structural positive for Kering's revenue mix that investors are rewarding.

  • Tariff refund probe and $400M Gucci Beauty exit cost Kering faces a class-action investigation over whether it kept tariff-related price hikes after tariffs were struck down, a potential legal and reputational risk. It also paid $400 million to end the Gucci beauty license early, a cash cost that partly offsets the positive results.

    These are real counterweights that could weigh on the stock and are new this period.

Hermes International SCA (RMS.PA)

Q3 2026
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.

July 2026
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.

Latest
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.